- About Us
- How We Work
- Our Insights
- BSR Conference
- Member Center
October 15, 2013
Companies are used to looking at supply chain risks related to labor or environmental impacts. But large, distributed supply chains and business networks facilitated by easy air travel are now exposing more people to emerging health risks.
October 11, 2013
Pharmaceutical companies have been working for years to prevent drug shortages, but they still happen. To address discontinuity of supply, pharmaceutical companies should collaborate within their industry and across sectors.
September 24, 2013
As the UN sets about establishing post-2015 development goals, we need new thinking and fresh commitments from across all sectors to develop—and meet—commitments related to global health.
July 11, 2013
To launch our new collaborative initiative, the Guiding Principles on Access to Healthcare, we hosted a webinar with representatives from many sectors in the healthcare industry. Here are three lessons about the principles that can help business tackle major sustainability issues—such as improving global health outcomes.
December 12, 2012
While working nearly a decade for a pharmaceutical think tank, I witnessed how great things can be accomplished when the barriers of competition fall. In my experience, collectively finding solutions not only generates recommendations, guidelines and best practices, it also fosters new models and pushes entire sectors towards faster progress. And today, faster progress is what we need to deliver safer, more affordable, and more effective medicine to larger populations.
December 1, 2012
While in Kenya this month, I sat in on a HERproject training on sexually transmitted infections (STIs) for future peer health educators. BSR’s HERproject uses a peer-to-peer training methodology to reach women working in factories and farms in Asia and Africa—to date, we’ve reached more than 200,000 women across eight countries.
September 4, 2012
In many ways, the health care industry has been able to address the world's health needs while also making a profit. But this win-win does not apply for certain types of diseases or for certain markets. Is it time for the industry to reconsider its business model?
August 20, 2012
From the “Oreo Cookie lawsuit” over trans-fat to the ban on Happy Meals in San Francisco to the tax on saturated fat in Denmark, the message is that corporate responsibility, when it comes to health and wellness, doesn’t exist and that only with the help of disincentives (in the form of regulations) are we going to help consumers make healthier choices.